|
|
|
Insider
Information: |
Gross Phillip |
Relationship: |
10% Owner |
City: |
Boston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
0 |
|
Indirect Shares
|
133,228,723 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$3,747,469,877 |
|
|
Total
Shares |
133,228,723 |
|
|
Total
Value |
$3,747,469,877 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
24
|
66
|
Stock
price went up :
|
8
|
10
|
Stock
price went down : |
16
|
56
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-3.8%
|
-765.9%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boulder Brands Inc |
BDBD |
10% Owner |
2007-09-07 |
0 |
2013-02-01 |
5,939,492 |
Premium* |
|
Hubbell Inc |
HUBB |
10% Owner |
|
0 |
2008-04-25 |
727,000 |
Premium* |
|
Pacific Sunwear Of California Inc |
PSUN |
10% Owner |
2008-07-11 |
0 |
2016-04-06 |
5,127,926 |
Premium* |
|
Sleep Number Corp |
SCSS |
See Remarks. |
|
0 |
2011-02-09 |
5,415,000 |
Premium* |
|
Celanese Corp |
CE |
10% Owner |
|
0 |
2009-02-02 |
13,588,774 |
Premium* |
|
AMAG Pharmaceuticals Inc |
AMAG |
10% Owner |
2009-03-04 |
0 |
2015-01-09 |
2,546,592 |
Premium* |
|
Correvio Pharma Corporation |
CORV |
10% Owner |
2009-04-09 |
0 |
2010-04-14 |
6,700,000 |
Premium* |
|
Mandalay Digital Group Inc |
MNDL |
10% Owner |
|
0 |
2012-03-01 |
10,053,333 |
Premium* |
|
Puma Biotechnology Inc |
PBYI |
10% Owner |
2012-04-26 |
0 |
2017-06-12 |
3,696,580 |
Premium* |
|
Concert Pharmaceuticals, Inc. |
CNCE |
10% Owner |
|
0 |
2014-02-20 |
510,147 |
Premium* |
|
HeartWare International Inc |
HTWR |
10% Owner |
|
0 |
2015-08-03 |
1,722,969 |
Premium* |
|
Calithera Biosciences, Inc. |
CALA |
10% Owner |
|
0 |
2017-09-28 |
3,546,873 |
Premium* |
|
Advaxis Inc |
ADXS |
10% Owner |
|
0 |
2017-10-11 |
4,100,043 |
Premium* |
|
Nexvet Biopharma Plc |
NVET |
10% Owner |
2014-02-10 |
0 |
2014-02-10 |
875,000 |
Premium* |
|
Five Prime Therapeutics Inc |
FPRX |
10% Owner |
|
0 |
2015-10-15 |
2,539,949 |
Premium* |
|
Vitae Pharmaceuticals, Inc |
VTAE |
10% Owner |
|
0 |
2016-09-14 |
2,375,000 |
Premium* |
|
Mulesoft, Inc |
MULE |
10% Owner |
2017-03-17 |
0 |
2017-03-17 |
675,000 |
Premium* |
|
Solaris Oilfield Infrastructure,... |
SOI |
10% Owner |
2017-05-12 |
0 |
2017-05-12 |
1,275,000 |
Premium* |
|
Protagonist Therapeutics, Inc |
PTGX |
10% Owner |
|
0 |
2017-05-30 |
2,056,076 |
Premium* |
|
Orbcomm Inc. |
ORBC |
10% Owner |
|
0 |
2020-08-12 |
7,697,220 |
Premium* |
|
Royalty Pharma Plc |
RPRX |
10% Owner |
2020-06-18 |
0 |
2020-12-18 |
38,714,280 |
Premium* |
|
Advent Technologies Holdings Ord... |
ADN |
10% Owner |
|
0 |
2020-12-03 |
781,535 |
Premium* |
|
Gcm Grosvenor Inc. |
GCMG |
10% Owner |
2021-05-18 |
0 |
2023-05-10 |
4,158,641 |
Premium* |
|
Abacus Life Ord Shs Class A |
ABL |
10% Owner |
|
0 |
2023-01-23 |
0 |
Premium* |
|
Abeona Therapeutics Inc |
ABEO |
10% Owner |
|
0 |
2023-07-03 |
3,249,994 |
Premium* |
|
EyePoint Pharmaceuticals Inc |
EYPT |
10% Owner |
|
0 |
2024-04-18 |
5,156,299 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
293 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BDBD |
Boulder Brands Inc |
10% Owner |
|
2013-01-28 |
4 |
S |
$13.52 |
$353,278 |
I/I |
(26,130) |
6,255,265 |
0 |
- |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2012-12-18 |
4 |
B |
$19.00 |
$504,640 |
I/I |
26,560 |
5,239,519 |
1.5 |
- |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2012-07-02 |
4 |
B |
$11.14 |
$300,780 |
I/I |
27,000 |
3,811,695 |
1.5 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2020-12-17 |
4 |
B |
$12.25 |
$362,952 |
I/I |
29,629 |
5,648,951 |
1.5 |
% |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2017-06-02 |
4 |
S |
$83.06 |
$2,531,287 |
I/I |
(30,475) |
4,250,968 |
0 |
- |
|
SCSS |
Sleep Number Corp |
10% Owner |
|
2011-01-28 |
4 |
S |
$10.21 |
$321,873 |
I/I |
(31,300) |
6,867,100 |
0 |
- |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2015-08-26 |
4 |
B |
$4.65 |
$149,070 |
I/I |
32,058 |
2,797,933 |
1.5 |
- |
|
HTWR |
HeartWare International I... |
10% Owner |
|
2014-09-12 |
4 |
B |
$76.34 |
$2,678,210 |
I/I |
34,900 |
1,941,236 |
1.5 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-05-06 |
4 |
S |
$13.33 |
$465,370 |
I/I |
(34,906) |
4,741,442 |
0 |
% |
|
HTWR |
HeartWare International I... |
10% Owner |
|
2015-08-03 |
4 |
S |
$90.02 |
$3,165,072 |
I/I |
(35,000) |
1,722,969 |
0 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-03-08 |
4 |
S |
$12.96 |
$455,410 |
I/I |
(35,000) |
5,189,031 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2014-10-15 |
4 |
B |
$6.80 |
$264,250 |
I/I |
38,000 |
2,765,675 |
1.5 |
- |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2017-09-28 |
4 |
S |
$15.50 |
$589,000 |
I/I |
(38,000) |
3,546,873 |
0 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2020-12-08 |
4 |
S |
$12.53 |
$501,930 |
I/I |
(39,986) |
5,916,412 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-04-27 |
4 |
S |
$13.00 |
$520,946 |
I/I |
(40,066) |
5,018,346 |
0 |
% |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2015-09-23 |
4 |
B |
$6.07 |
$243,768 |
I/I |
40,168 |
3,135,069 |
1.5 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-06-07 |
4 |
B |
$10.71 |
$440,342 |
I/I |
41,115 |
4,734,799 |
1.5 |
% |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2015-09-22 |
4 |
B |
$6.00 |
$250,938 |
I/I |
41,800 |
3,094,901 |
1.5 |
- |
|
CALA |
Calithera Biosciences, In... |
10% Owner |
|
2015-08-28 |
4 |
B |
$5.55 |
$237,645 |
I/I |
42,700 |
2,937,801 |
1.5 |
- |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-02-05 |
4 |
S |
$13.41 |
$580,551 |
I/I |
(43,029) |
5,435,755 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2023-05-09 |
4 |
S |
$7.69 |
$335,260 |
I/I |
(43,560) |
4,274,489 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-04-30 |
4 |
S |
$13.25 |
$592,582 |
I/I |
(44,708) |
4,834,338 |
0 |
% |
|
GCMG |
Gcm Grosvenor Inc. |
10% Owner |
|
2021-02-22 |
4 |
B |
$12.75 |
$588,139 |
I/I |
46,000 |
5,332,807 |
1.5 |
% |
|
AMAG |
AMAG Pharmaceuticals Inc |
10% Owner |
|
2012-03-02 |
4 |
B |
$15.97 |
$751,133 |
I/I |
47,034 |
4,135,330 |
1.5 |
- |
|
PBYI |
Puma Biotechnology Inc |
10% Owner |
|
2012-12-07 |
4 |
B |
$18.95 |
$910,550 |
I/I |
48,040 |
5,090,559 |
1.5 |
- |
|
293 Records found
|
|
Page 6 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|